Two molecules matter for detection. Nicotine itself has a plasma half-life of approximately 1-2 hours. After inhalation or vape, nicotine peaks within minutes, then clears rapidly: 50% gone within 2 hours, 75% within 4 hours, undetectable in plasma within 24 hours. Cotinine is nicotine’s primary metabolite (produced in the liver via the CYP2A6 enzyme). It has a much longer half-life: 16-19 hours per Mayo Medical Labs and CDC consensus, with a 2016 review suggesting up to 40 hours upper bound. Because cotinine is more stable and longer-lasting, virtually all UK nicotine testing measures cotinine rather than nicotine.

Detection windows differ by sample type. Blood: nicotine 1-3 days, cotinine up to 10 days in heavy users. Urine: nicotine 3-4 days, cotinine up to 3 weeks in heavy users (urine cotinine concentrations are 4-6 times higher than blood/saliva per a 2016 Journal of Clinical and Diagnostic Research review). Saliva: cotinine up to 4 days, the most sensitive test for recent use. Hair: cotinine up to 90 days (12 months in chronic users), the longest detection window but requires hair sampling. Breath: 12-24 hours, used for breath CO testing in some UK NHS Stop Smoking Services. Breastmilk: complete nicotine elimination around 10 hours, halved within 2 hours.

For specific UK testing contexts: life insurance underwriting typically uses urine cotinine, sometimes blood. Pre-surgery cotinine testing (especially bariatric surgery) is common in UK NHS hospitals: a 2019 study found cotinine urine tests had high sensitivity and specificity for smoking within the previous 72 hours. A 2020 study found cotinine could be detected in urine for up to 8 weeks in some heavy users. Family court may order cotinine testing in child contact cases. Workplace testing varies by employer (most UK workplaces do not test for nicotine specifically). Notably, you cannot meaningfully speed up nicotine elimination: hydration, exercise and diet may have marginal effects but the half-life is genetically determined by your CYP2A6 enzyme variant.

Why cotinine is the standard test, not nicotine

Three reasons cotinine has become the standard nicotine biomarker. First, stability: cotinine’s 16-19 hour half-life means it remains detectable in body fluids for days after exposure, providing reliable evidence of nicotine use. Nicotine itself drops below detection within 24 hours, missing anyone who paused for a day. Second, specificity: the only way cotinine appears in your body is through nicotine exposure. Your body does not produce cotinine endogenously. So a positive cotinine test is definitive evidence of nicotine exposure. Third, sensitivity: cotinine concentrates in urine at 4-6 times the level in blood or saliva, making urine cotinine tests very sensitive even for light or occasional users. UK clinical and forensic testing labs (NHS hospital biochemistry, private testing companies like Cansford Laboratories, MEDIChem, ClearTest) all use cotinine as the primary marker. Some specialised tests add detection of other metabolites (trans-3-hydroxycotinine, nicotine N-oxide) for additional detail but cotinine remains the standard.

Individual variation in nicotine and cotinine clearance

The 1-2 hour nicotine half-life and 16-19 hour cotinine half-life are population averages. Individual UK adults vary substantially based on five factors. First, genetics: the CYP2A6 enzyme that metabolises nicotine to cotinine has multiple variants. Some variants metabolise nicotine quickly (fast metabolisers, shorter half-life, lower cotinine levels), others slowly (slow metabolisers, longer half-life, higher cotinine levels). Around 10% of UK adults are slow metabolisers due to CYP2A6 variants. Second, age: older adults (over 65) process nicotine up to 23% slower than younger adults. Third, sex: women generally metabolise nicotine faster than men, especially during pregnancy due to oestrogen effects on CYP2A6. Fourth, liver and kidney function: chronic liver disease or kidney disease slows clearance significantly. Fifth, frequency and amount of use: heavy chronic users have higher baseline cotinine and longer detection windows because of accumulation in tissues. These factors mean two UK vapers with identical usage patterns can have substantially different test results.

Can you speed up nicotine clearance? (Short answer: not really)

Many websites claim that hydration, exercise, sauna, vitamin C or specific foods can speed nicotine and cotinine clearance. The reality is more limited. The rate-limiting step in nicotine clearance is the CYP2A6 enzyme in your liver, and that runs at a fixed rate determined by your genetics. The only intervention that meaningfully changes this is stopping nicotine use (so no new nicotine enters the body) and waiting. That said, three approaches have marginal effects. First, hydration: increased water intake increases urine output, which slightly increases urinary cotinine excretion. The effect is modest, perhaps 10-20% faster urine clearance. Second, exercise: improves overall metabolism and sweating may excrete tiny amounts of nicotine. Effect is small. Third, cruciferous vegetables (broccoli, cabbage, kale): contain compounds that may modestly induce CYP2A6 activity. Effect is small and inconsistent. The honest answer: no reliable way to dramatically speed up nicotine and cotinine clearance. If you have a pending UK test (insurance, pre-surgery, court), abstinence is the only effective strategy and you need to plan adequate time based on detection windows.

For UK adults preparing for testing or curious about detection times, the four-sample reference below summarises NHS and laboratory consensus.

For UK adults with pending tests (life insurance, pre-surgery, family court), plan abstinence based on the relevant detection window. There is no reliable shortcut: CYP2A6 enzyme function is genetically determined. For pre-surgery testing in NHS hospitals (especially bariatric), be honest with your surgeon: deception risks surgical complications. Our Omagh and Strabane teams can advise on cessation pathways for UK adults planning testing situations, including stepdown protocols and NRT alternatives.